Cannabidiol (Epidyolex)
Cannabidiol risk profile, scheduling, and guidance for claims professionals and care workers . Also known as Epidyolex.
Cannabidiol (brand names: Epidyolex) is classified as Moderate risk (5 risk points) by AllMeds. It is a S8 medication under the TGA in Australia. Controlled cannabis medicine with significant CNS effects and workplace impairment risk.
Key Takeaways
- TGA Schedule: S8 in Australia
- Risk level: Moderate (5 points)
- CNS depressant: May cause sedation, impair driving, and affect work capacity
- Recommended maximum duration: 90 days
- SIRA reportable: Flagged for NSW workers compensation reporting
- PBS listed: Subsidised under the Australian Pharmaceutical Benefits Scheme
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S8 | PBS listed |
Risk Profile
Controlled cannabis medicine with significant CNS effects and workplace impairment risk.
Regulatory and Compliance Guidance
When Cannabidiol appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Work capacity impact: As a CNS depressant, Cannabidiol may impair driving, operating machinery, and cognitive function. Work capacity certificates should reflect any medication-related restrictions.
Australia TGA / PBS / State Schemes
Classified as S8 under the Therapeutic Goods Administration (TGA).
Listed on the Pharmaceutical Benefits Scheme (PBS) for subsidised prescribing.
Flagged as reportable under SIRA guidelines in NSW. Claims involving this medication may require additional reporting and clinical justification.
Need to assess this medication across your caseload?
Run a full risk assessment including Cannabidiol interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.